Cytoreductive surgery for malignant peritoneal mesothelioma: importance of patient selection using diagnostic laparoscopy

November 16, 2026 | Comments Off on Cytoreductive surgery for malignant peritoneal mesothelioma: importance of patient selection using diagnostic laparoscopy

Japanese Journal of Clinical Oncology 2026 September 24 [Link] Akiyoshi Mizumoto, Nobuyuki Takao, Toru Imagami, Atsushi Hirata, Yasumitsu Oe, Takashi Matsunaga, Akira Sogawa, Byonggu An, Takeshi Togawa Abstract Background: Malignant…

Low frequency of MTAP co-deletion with CDKN2A in peritoneal mesothelioma suggests an independent diagnostic role for MTAP

November 13, 2026 | Comments Off on Low frequency of MTAP co-deletion with CDKN2A in peritoneal mesothelioma suggests an independent diagnostic role for MTAP

Histopathology 2026 September 21 [Link] Andrea Quaranta, Donato Mancini, Concetta Caporusso, Andrea Marzullo, Luigi Vimercati, Cecilia Salzillo, Federica Pezzuto, Fiorella Calabrese, Gabriella Serio Abstract Aims: Loss of MTAP expression by…

Diffuse Pleural Mesothelioma Initially Presenting as Cervical Lymphadenopathy: A Report of a Rare Case

November 12, 2026 | Comments Off on Diffuse Pleural Mesothelioma Initially Presenting as Cervical Lymphadenopathy: A Report of a Rare Case

Cureus 2026 August 20 [Link] Kaushik Saha, Sayantika Ghosh, Soumita Poddar Abstract Diffuse mesothelioma is a rare malignant tumor arising from mesothelial cells, showing diffuse involvement of the pleura and…

Patient-Derived Organoid Models and Precision HIPEC in Diffuse Malignant Peritoneal Mesothelioma: Modeling Heterogeneity to Address Recurrence

November 11, 2026 | Comments Off on Patient-Derived Organoid Models and Precision HIPEC in Diffuse Malignant Peritoneal Mesothelioma: Modeling Heterogeneity to Address Recurrence

International Journal of Molecular Sciences 2026 September 4 [Link] Eleftherios A Makris, James K Ives, Konstantinos Votanopoulos Abstract Diffuse malignant peritoneal mesothelioma (DMPM) is a rare malignancy for which cytoreductive…

BAP1 Loss in Pleural Mesothelioma Is Associated With Reduced Soluble CCL2 in Patient Effusion, Abrogated CCL2-Mediated Monocyte Recruitment In Vitro

November 10, 2026 | Comments Off on BAP1 Loss in Pleural Mesothelioma Is Associated With Reduced Soluble CCL2 in Patient Effusion, Abrogated CCL2-Mediated Monocyte Recruitment In Vitro

JTO Clinical and Research Reports 2026 July 10 [Link] Alistair Nash, Ebony Rouse, Tina Firth, Ian M Dick, Vanessa S Fear, Catherine A Forbes, Amber Louw, Y C Gary Lee,…

Prognostic value of SUVpeak and prognostic nutritional index in patients with pleural mesothelioma treated with platinum-based chemotherapy

November 9, 2026 | Comments Off on Prognostic value of SUVpeak and prognostic nutritional index in patients with pleural mesothelioma treated with platinum-based chemotherapy

Translational Lung Cancer Research 2026 August 31 [Link] Yoshiki Kato, Kosuke Hashimoto, Hisao Imai, Kyoichi Kaira, Reina Ishii, Naohito Hashimoto, Ou Yamaguchi, Atsuto Mouri, Hiroshi Kagamu, Ichiei Kuji Abstract Background:…

Using an artificial intelligence tool to improve the recognition of pseudoprogression in pleural mesothelioma patients treated with immunotherapy: a case series

November 6, 2026 | Comments Off on Using an artificial intelligence tool to improve the recognition of pseudoprogression in pleural mesothelioma patients treated with immunotherapy: a case series

Translational Lung Cancer Research 2026 August 31 [Link] Illaa Smesseim, Kalina Chupetlovska, Valerio Pugliese, Jacobus A Burgers, Kevin B W Groot Lipman Abstract Background: Pseudoprogression, defined as initial radiological tumor…

Hyperthermic intrathoracic chemotherapy after cytoreductive surgery in malignant pleural mesothelioma: a single-center retrospective cohort study suggesting increased morbidity without survival benefit

November 5, 2026 | Comments Off on Hyperthermic intrathoracic chemotherapy after cytoreductive surgery in malignant pleural mesothelioma: a single-center retrospective cohort study suggesting increased morbidity without survival benefit

Journal of Thoracic Disease 2026 August 31 [Link] Natalie Baldes, Fabian Doerr, Konstantinos Grapatsas, Balazs Hegedüs, Martin Metzenmacher, Dirk Theegarten, Christian Taube, Martin Schuler, Servet Bölükbas Abstract Background: In the…

Mesenteric Peritonectomy as the Seventh Peritonectomy Technique in Cytoreductive Surgery for Peritoneal Surface Malignancies: A Propensity Score-Matched Analysis

November 4, 2026 | Comments Off on Mesenteric Peritonectomy as the Seventh Peritonectomy Technique in Cytoreductive Surgery for Peritoneal Surface Malignancies: A Propensity Score-Matched Analysis

Annals of Surgical Oncology 2026 September 11 [Link] Francesca Laura Nava, Tommaso Cavalleri, Dario Baratti, Marcello Guaglio, Shigeki Kusamura, Marcello Deraco Abstract Background: Mesenteric involvement represents a major challenge in…

Long-term real-world outcomes of nivolumab+ipilimumab treatment of unresectable pleural mesothelioma: update of Meso-Immune GFPC 04-2021 study

November 3, 2026 | Comments Off on Long-term real-world outcomes of nivolumab+ipilimumab treatment of unresectable pleural mesothelioma: update of Meso-Immune GFPC 04-2021 study

Lung Cancer 2026 November [Link] Jean-Baptiste Assié, Laurent Greillier, Aurelien Gobert, Lionel Falchero, Lise Thibonnier, Matthieu Chasseray, Christine Raynaud, Hugo Picchi, Thierry Chatellier, Romain Corre, Olivier Molinier, Alain Bakebe, Charles…

Categories